Home > Francesco Boscia, ISOPT 2018 – Anti-VEGF treatment regimens in DME
Diabetic Macular Oedema, Retina/Vitreous

Francesco Boscia, ISOPT 2018 – Anti-VEGF treatment regimens in DME

Published Online: March 5th 2018

Francesco Boscia shares his thoughts on selecting the appropriate intravitreal anti-VEGF therapy and approach to patients who are not responding to treatment.

Share this Video
Related Videos In Retina/Vitreous
Retina/Vitreous
Roxane Hillier, EURETINA 2021: Retinal Recovery after Pneumatic Retinopexy

We were delighted to catch up with Roxane Hillier (Newcastle Eye Centre, Newcastle, UK), who gave us her insights on the impact of pneumatic retinopexy (PnR) on vision-related quality of life, and retinal recovery following PnR. Questions What is the impact of pneumatic retinopexy (PnR) on vision-related quality of life? (00:13) What is known about […]

Retina/Vitreous
Roxane Hillier, EURETINA 2021: Pneumatic Retinopexy for the Management of Rhegmatogenous Retinal Detachment

It was wonderful to speak with Roxane Hillier (Newcastle Eye Centre, Newcastle, UK) about the advantages of pneumatic retinopexy compared with pars plana vitrectomy for the management of rhegmatogenous retinal detachment. Questions Why has the optimal surgical technique for the treatment of rhegmatogenous retinal detachment (RRD) been controversial? (00:12) What are the advantages of pneumatic […]

Retina/Vitreous
Paisan Ruamviboonsuk, EURETINA 2021: Artificial Intelligence Platforms for Diagnosis and Screening for Polypoidal Choroidal Vasculopathy

We enjoyed catching up with Paisan Ruamviboonsuk (Rajavithi Hospital, Bangkok, Thailand) about the clinical evidence supporting the use of artificial intelligence platforms in diagnosis and screening for polypoidal choroidal vasculopathy, and the unanswered questions that remain. Questions What clinical evidence supports the use of artificial intelligence platforms in the diagnosis and screening for polypoidal choroidal […]

Trending In Retina/Vitreous:

Roxane Hillier, EURETINA 2021: Retinal Recovery after Pneumatic Retinopexy
Retina/Vitreous
    • Copied to clipboard!
    accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72